Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, today announced its participation in ...
Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024 ...
Late-breaking presentations will reveal important new data from the phase III OLYMPIA and ARCADIA trials, including durability and long-term efficacy ...
Galderma to showcase updates from across its industry-leading dermatology portfolio at 33rd EADV congress: Zug, Switzerland Thursday, September 19, 2024, 18:00 Hrs [IST] Galderma, ...
高德美(瑞士证券交易所:股票代码为"GALD")致力于成为专注皮肤学领域的全球领导者,业务遍及约90个国家和地区。我们提供创新、以科学为基础的优质旗舰品牌和服务组合,横跨注射美学、日常护肤和皮肤治疗这三个快速增长的皮肤学细分市场。自1981年成立以来 ...